Hospital readmission penalties 2027: 80% of hospitals docked
CMS cut Medicare payments for 2,334 hospitals starting Oct. 1, the first cycle to count Medicare Advantage patients in the measure and the first to shorten the lookback to two years.
The hospital readmission penalties 2027 cycle took effect Oct. 1, and it is not a routine repeat of prior years. CMS is reducing Medicare payments at 2,334 hospitals, roughly 80% of those evaluated, up from 2,304 a year earlier. Two structural changes landed at the same time: Medicare Advantage beneficiaries now count toward the measures, and the performance window shrank from three years to two. Together they change how fast clinical performance converts into dollars.
CMS data via Becker's Hospital Review
| Value (% of evaluated hospitals) | FY2026 | FY2027 |
|---|---|---|
| No penalty | 21.8 % of evaluated hospitals | 19.8 % of evaluated hospitals |
| Penalty under 1% | 70.1 % of evaluated hospitals | 71.8 % of evaluated hospitals |
| Penalty of 1% or more | 8.1 % of evaluated hospitals | 8.4 % of evaluated hospitals |
What changed in the FY2027 HRRP calculation
The Hospital Readmissions Reduction Program has been a fixture since 2012, but fiscal 2027 is the first cycle in which CMS calculated performance using both Medicare Advantage and traditional fee-for-service data. CMS adopted the MA-inclusion policy in the FY 2026 IPPS rulemaking and shortened the performance period from three years to two beginning with FY 2027.
The asymmetry matters. Measurement now covers a far larger slice of a hospital's Medicare population, but the payment adjustment still applies only to traditional Medicare inpatient payments. A system with deep MA penetration absorbs measurement risk from patients whose discharges generate no penalty exposure at all. The reverse is also true: care-management investments aimed at MA members, previously invisible to HRRP, now show up in the numerator and denominator.
The shortened lookback removes a shock absorber. Under a three-year window, a single disrupted year could be diluted by two stronger ones. With two years, recent performance carries proportionally more weight, and recovery from a bad stretch takes less time but arrives with less warning.
The penalty is not applied to readmissions. It is applied to every fee-for-service discharge for a full year.
How the penalty distribution shifted
The movement year over year is modest in aggregate and meaningful at the tails. Hospitals escaping any penalty fell from 641 to 578, or from 21.8% to 19.8% of those evaluated. Hospitals facing cuts of 1% or more rose from 240 to 244, which is 8.4% of the evaluated field. Ten hospitals face the statutory maximum 3% reduction, and 34 face 2% or more.
Hospitals with the highest share of dual-eligible patients see an average penalty of 0.33%, flat against fiscal 2026. The peer-grouping adjustment, designed to compare safety-net hospitals against similar institutions rather than the full field, is holding the line but not producing relief. For operators serving large dual-eligible populations, the FY2027 cycle is a continuation of pressure, not an easing of it.
Context from the program's history is worth keeping in view: KFF has found that 93% of eligible hospitals were penalized at least once during the program's first decade. Being penalized is the baseline condition, not the exception. The strategic question is the size of the adjustment, not whether one appears.
Why the dollar impact is larger than the percentage suggests
The most common misreading of HRRP is treating the penalty as a reduction applied to readmissions. It is not. The adjustment reduces Medicare inpatient payments on every fee-for-service discharge for the full fiscal year, up to 3%. A 0.5% penalty at a hospital with substantial traditional Medicare inpatient volume is a seven-figure run-rate item at many mid-sized facilities, and it compounds with other IPPS adjustments landing in the same year.
CMS also projected in the FY 2027 IPPS final rule that the sepsis readmission measure alone reduces expenditures by $0 to $170 million, using an $85 million midpoint, with penalties reaching an estimated 2,832 hospitals, or 83.26% of eligible hospitals, under that modeling. Sepsis is now a measured condition with real payment consequences, and it behaves differently from the heart failure and pneumonia cohorts most readmission programs were built around.
What CFOs, COOs and CMOs should do in the next two quarters
Finance leaders should have the FY2027 adjustment already modeled into run-rate, not treated as a year-end variance. The penalty has a 12-month payment tail that began Oct. 1, so the revenue effect is known and should be booked against budget rather than discovered in the monthly close.
Operations and clinical leadership need to re-scope transitions-of-care, post-acute network management and discharge follow-up programs to include Medicare Advantage patients. Many systems built these programs around fee-for-service attribution because that is where the penalty lived. That design assumption is now obsolete on the measurement side. Review which MA members fall into the measure cohorts and whether existing care-management staffing covers them.
Quality teams should recalibrate improvement timelines to the two-year window. Interventions launched now influence a smaller, nearer window, which means both faster payoff and less time to demonstrate sustained gains. Safety-net operators should assume flat dual-eligible penalties and plan around them rather than waiting on a peer-grouping adjustment to improve the picture.
